% | $
Quotes you view appear here for quick access.

Neuralstem, Inc. Message Board

  • alex1444 alex1444 Jun 27, 2013 11:30 AM Flag

    Coming soon

    Russell rebalance activity (tomorrow, especially AH)
    CNN ALS report (Monday-Wednesday next week)
    Spinal Cord trial begins, South Korea (Q3)
    Ischemic Stroke trial begins, China (Q3)
    ALS trial Phase 2 beings, USA (Q3)
    NSI-189 Phase 1B data released (Q3)

    Already in Q2:
    Data strongly suggests NSI-566 will stabilize ALS in most patients.
    ALS Phase 2 aprpoved by FDA, joined by U of Michigan.
    NFL Alumni Association partners with CUR in future NSI-189 trials on concussion/brain injury victims.

    Possible in Q3:
    Partnership with Mexican pharma on ALS.
    Partnership with US pharma on NSI-189 for major depression, PTSD, Alzheimer's, TBI

    Yep, this is just another GERN circa 2000-2011, just spinning wheels and getting nothing done, nothing on the horizon. No reason to be in this stock.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I forgot one more event of significance, potentially in Q3, though much more likely in Q4. The detailed, peer-reviewed, published data of Dr. Feldman's ALS work with CUR/NSI-566. Presumably in a major medical publication. That is expected "this fall", which might not mean Q3, then again it might. Fall begins after the 3rd week of September, so technically Q3 is unlikely. Then again, some people think of all of September as being "fall", even though it is not.

      Sentiment: Strong Buy

    • Actually, CUR has 1/2 the value of GERN which is not even in the stem cell game. That was the point; you missed it.

      • 1 Reply to crease24
      • Ah ok, what a great point Crease24. Would you also like to tell us how CUR's market cap compares with AAPL? Apple is not in the stem cell game either.

        By the way, how do you feel about selling out of your CUR shares on February 28 (you: "I'm out. This is garbage"), when the high was $1.11, low and close were $1.06? Regret that much? And you were so bullish on CUR up until then, that must hurt.

        Hey I regret selling out of SRCL in 1999. I had been so bullish on it (even posted a lot of messages on that Yahoo Finance message board at that time). I thought I could get back in any time, and probably cheaper than where I sold. I was wrong on that one, big time. It happens. But I didn't bash SRCL after I sold, in a futile effort to get back in at a cheap price. I figured my options were to either buy back in or move on. Perhaps you'll see things that way too, some day.

        Sentiment: Strong Buy

0.3498-0.0002(-0.06%)May 4 4:00 PMEDT